Latorzeff I, Antoni D, Josset S, Noël G, Tallet-Richard A (2022) Radiation therapy for brain metastases. Cancer Radiother 26(1):129–136
Article CAS PubMed Google Scholar
Kocher M, Soffietti R, Abacioglu U, Villà S, Fauchon F, Baumert BG et al (2011) Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952–26001 study. J Clin Oncol 29(2):134–141
Ra P, Pa T, Wf R, Rj D, M M, Rj K et al (1998) Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 280(17) (https://pubmed.ncbi.nlm.nih.gov/9809728/)
Keller A, Doré M, Cebula H, Thillays F, Proust F, Darié I et al (2017) Hypofractionated stereotactic radiation therapy to the resection bed for intracranial metastases. Int J Radiat Oncol Biol Phys 99(5):1179–1189
Redmond KJ, De Salles AAF, Fariselli L, Levivier M, Ma L, Paddick I et al (2021) Stereotactic radiosurgery for postoperative metastatic surgical cavities: a critical review and international stereotactic radiosurgery society (ISRS) practice guidelines. Int J Radiat Oncol Biol Phys 111(1):68–80
Brown PD, Ballman KV, Cerhan JH, Anderson SK, Carrero XW, Whitton AC et al (2017) Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial. Lancet Oncol 18(8):1049–1060
Article PubMed PubMed Central Google Scholar
Mahajan A, Ahmed S, McAleer MF, Weinberg JS, Li J, Brown P et al (2017) Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial. Lancet Oncol 18(8):1040–1048
Article PubMed PubMed Central Google Scholar
Asher AL, Burri SH, Wiggins WF, Kelly RP, Boltes MO, Mehrlich M et al (2014) A new treatment paradigm: neoadjuvant radiosurgery before surgical resection of brain metastases with analysis of local tumor recurrence. Int J Radiat Oncol Biol Phys 88(4):899–906
Prabhu RS, Akinyelu T, Vaslow ZK, Matsui JK, Haghighi N, Dan T et al (2023) Risk factors for progression and toxic effects after preoperative stereotactic radiosurgery for patients with resected brain metastases. JAMA Oncol 9(8):1066–1073
Article PubMed PubMed Central Google Scholar
Vetlova E, Golbin DA, Golanov AV, Potapov AA, Banov SM, Antipina N et al (2017) Preoperative stereotactic radiosurgery of brain metastases: preliminary results. Cureus 9(12):e1987
PubMed PubMed Central Google Scholar
Patel KR, Burri SH, Asher AL, Crocker IR, Fraser RW, Zhang C et al (2016) Comparing preoperative with postoperative stereotactic radiosurgery for resectable brain metastases: a multi-institutional analysis. Neurosurgery 79(2):279
Dharnipragada R, Dusenbery K, Ferreira C, Sharma M, Chen CC (2023) Preoperative versus postoperative radiosurgery of brain metastases: a meta-analysis. World Neurosurg 182:35–41
Biau J, Guillemin F, Ginzac A, Villa J, Truc G, Antoni D et al (2024) Preoperative stereotactic radiotherapy for the management of brain metastases. Cancer Radiother 28(6):534–537
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews | The BMJ. https://www.bmj.com/content/372/bmj.n71. Accessed 30 Dec 2024
Prabhu RS, Akinyelu T, Vaslow ZK, Matsui JK, Haghighi N, Dan T et al (2024) Single-fraction versus fractionated preoperative radiosurgery for resected brain metastases: a PROPS-BM international multicenter cohort study. Int J Radiat Oncol 118(3):650–661
Patel AR, Nedzi L, Lau S, Barnett SL, Mickey BE, Moore W et al (2018) Neoadjuvant stereotactic radiosurgery before surgical resection of cerebral metastases. World Neurosurg 120:e480–e487
Udovicich C, Ng SP, Tange D, Bailey N, Haghighi N (2022) From postoperative to preoperative: a case series of hypofractionated and single-fraction neoadjuvant stereotactic radiosurgery for brain metastases. Oper Neurosurg 22(4):208–214
Prabhu RS, Miller KR, Asher AL, Heinzerling JH, Moeller BJ, Lankford SP et al (2018) Preoperative stereotactic radiosurgery before planned resection of brain metastases: updated analysis of efficacy and toxicity of a novel treatment paradigm. J Neurosurg 131(5):1387–1394
Prabhu RS, Dhakal R, Vaslow ZK, Dan T, Mishra MV, Murphy ES et al (2021) Preoperative radiosurgery for resected brain metastases: the PROPS-BM multicenter cohort study. Int J Radiat Oncol 111(3):764–772
Atalar B, Modlin LA, Choi CYH, Adler JR, Gibbs IC, Chang SD et al (2013) Risk of leptomeningeal disease in patients treated with stereotactic radiosurgery targeting the postoperative resection cavity for brain metastases. Int J Radiat Oncol 87(4):713–718
Deguchi S, Mitsuya K, Yasui K, Kimura K, Onoe T, Ogawa H et al (2022) Neoadjuvant fractionated stereotactic radiotherapy followed by piecemeal resection of brain metastasis: a case series of 20 patients. Int J Clin Oncol 27(3):481–487
Perlow HK, Ho C, Matsui JK, Prasad RN, Klamer BG, Wang J et al (2022) Comparing pre-operative versus post-operative single and multi-fraction stereotactic radiotherapy for patients with resectable brain metastases. Clin Transl Radiat Oncol 38:117–122
PubMed PubMed Central Google Scholar
Kotecha R, Tonse R, Menendez MAR, Williams A, Diaz Z, Tom MC et al (2022) Evaluation of the impact of pre-operative stereotactic radiotherapy on the acute changes in histopathologic and immune marker profiles of brain metastases. Sci Rep 12(1):4567
Article CAS PubMed PubMed Central Google Scholar
Li YD, Coxon AT, Huang J, Abraham CD, Dowling JL, Leuthardt EC et al (2022) Neoadjuvant stereotactic radiosurgery for brain metastases: a new paradigm. Neurosurg Focus 53(5):E8
Article PubMed PubMed Central Google Scholar
Mallela AN, Iheagwara UK, Fogg D, Anthony A, Gersey ZC, Zhang X et al (2024) Preoperative stereotactic radiosurgery for cerebral metastases: safe, effective, and decreases steroid dependency. J Neurosurg: 1–11
Agrawal N, Shireman JM, Shiue K, Kamer A, Boyd L, Zang Y et al (2024) Preoperative stereotactic radiosurgery for patients with 1–4 brain metastases: a single-arm phase 2 trial outcome analysis (NCT03398694). Neurooncol Pract: npae43
NRG Oncology A randomized phase III trial of pre-operative compared to post-operative stereotactic radiosurgery in patients with resectable brain metastases. https://clinicaltrials.gov/study/NCT05438212. Accessed 10 Nov 2024
M.D. Anderson Cancer Center A phase III trial of pre-operative stereotactic radiosurgery (SRS) versus post-operative SRS for brain metastases. https://clinicaltrials.gov/study/NCT03741673. Accessed 10 Nov 2024
Mayo Clinic Pre-operative vs. Post-operative stereotactic radiosurgery for operative metastatic brain tumors. https://clinicaltrials.gov/study/NCT03750227. Accessed 14 Dec 2024
Sperduto PW, De B, Li J, Carpenter D, Kirkpatrick J, Milligan M et al (2022) Graded prognostic assessment (GPA) for patients with lung cancer and brain metastases: initial report of the small cell lung cancer GPA and update of the non-small cell lung cancer GPA including the effect of programmed death ligand 1 and other prognostic factors. Int J Radiat Oncol Biol Phys 114(1):60–74
Article PubMed PubMed Central Google Scholar
Wiggenraad R, de Kanter AV, Kal HB, Taphoorn M, Vissers T, Struikmans H (2011) Dose–effect relation in stereotactic radiotherapy for brain metastases. A systematic review. Radiother Oncol 98(3):292–297
Gagliardi F, De Domenico P, Snider S, Nizzola MG, Mortini P (2023) Efficacy of neoadjuvant stereotactic radiotherapy in brain metastases from solid cancer: a systematic review of literature and meta-analysis. Neurosurg Rev 46(1):130
https://www.sfdermato.org/upload/recommandations/referentiel-anocef-meta-cerebrales-de-melanome-de5a28d65e7991728ee21168d163cbc0.pdf. Accessed 11 Nov 2024
Centre Jean Perrin Phase II study to assess preoperative hypofractionated stereotactic radiotherapy of brain metastases. https://clinicaltrials.gov/study/NCT04503772. Accessed 10 Nov 2024
Ginzac A, Dupic G, Brun L, Molnar I, Casile M, Durando X et al (2021) Preoperative stereotactic radiosurgery for brain metastases: the STEP study protocol for a multicentre, prospective, phase-II trial. BMC Cancer 21(1):864
Article PubMed PubMed Central Google Scholar
AHS Cancer Control Alberta A randomized controlled trial of pre-operative versus post-operative stereotactic radiosurgery for patients with surgically resectable brain metastases. https://clinicaltrials.gov/study/NCT04474925. Accessed 10 Nov 2024
Comments (0)